Clinical Trial Update: Olaparib In Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

The document provides an update on a Phase 2 clinical trial of olaparib for metastatic breast cancer, indicating the study involves BRCA1/BRCA2 and other gene m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Lynparza (olaparib)

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Metastatic Breast Cancer, Invasive Breast Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING